Financial Performance - Net sales for Q1 2025 were $113.2 million, a 2.0% increase compared to $111.0 million in Q1 2024[6] - Operating income increased by 33.5% from $4.6 million in Q1 2024 to $6.2 million in Q1 2025[6] - Net income attributable to common shareholders increased by 104.5% from $2.3 million in Q1 2024 to $4.7 million in Q1 2025[6] - Adjusted EBITDA increased by 20.0% from $9.2 million in Q1 2024 to $11.0 million in Q1 2025[6] - Diluted EPS increased by 108.6% from $0.12 in Q1 2024 to $0.25 in Q1 2025[6] Balance Sheet and Cash Flow - Cash and cash equivalents totaled $86.5 million as of March 31, 2025[9, 10] - The company has zero debt as of March 31, 2025[9, 10] - Cash from operations totaled $2.6 million for Q1 2025[9, 10] - Free cash flow totaled $1.5 million for Q1 2025[9, 10] Sales by Operating Segment - Asia net sales increased by 5.3% from $46.22 million in Q1 2024 to $48.653 million in Q1 2025[11] - Europe net sales increased by 8.2% from $22.296 million in Q1 2024 to $24.114 million in Q1 2025[11] - North America net sales decreased by 4.1% from $36.525 million in Q1 2024 to $35.018 million in Q1 2025[11]

Q3 FY25 Performance Highlights - Q3 revenue and EPS exceeded guidance, driven by strong cloud demand[8] - Revenue increased by 8% QoQ and 16% YoY, primarily due to hyperscale cloud growth[8] - The company is on track to more than double EML shipments by the end of CY25, relative to the June 2024 baseline[8] Q3 FY25 Financial Results (Non-GAAP) - Revenue was $4252 million[10] - Gross margin reached 352%[10] - Operating income was $461 million, representing 108% of revenue[10] - Diluted EPS stood at $057[10] Segment Performance - Cloud & Networking revenue was $3652 million[11] - Industrial Tech revenue was $600 million[11] - Cloud & Networking segment profit margin was 200%[11] - Industrial Tech segment profit margin was 43%[11] Q4 FY25 Guidance (Non-GAAP) - Revenue is projected to be between $440 million and $470 million[13] - Operating margin is expected to be in the range of 130% to 140%[13] - Diluted EPS is forecasted to be between $070 and $080[13]

Q1 2025 Financial Performance - Originations reached $2.1 billion, an increase of 89% year-over-year[9, 13] - Total revenue was $213 million, up 67% year-over-year[9, 19] - The company achieved near breakeven GAAP net loss of ($2 million)[9] - Adjusted EBITDA was $43 million, representing a 20% margin[9, 25] - Contribution profit was $102 million, with a 55% contribution margin, reflecting expansion into super-prime and new products[22] Q1 2025 Loan Metrics - 241,000 loans were transacted with a 19.1% conversion rate[16] - Personal loan originations grew 83% year-over-year to $2.0 billion[39] - Auto originations grew 5X since Q1 2024 to $61 million, a 42% sequential increase[45] - Home originations grew 6X since Q1 2024 to $41 million, a 52% sequential increase[49] - 92% of loans were fully automated, with no human intervention by Upstart[33, 36] Q2 2025 and FY 2025 Outlook - Q2 2025 total revenue is projected at $225 million[26] - Q2 2025 revenue from fees, net is projected at $210 million[26] - Q2 2025 net interest income is projected at $15 million[26] - FY 2025 total revenue is projected at $1.01 billion[26] - FY 2025 revenue from fees, net is projected at $920 million[26] - FY 2025 net interest income is projected at $90 million[26] - The company anticipates positive GAAP net income in the second half of 2025 and for the full year[26] - FY 2025 Adjusted EBITDA Margin is expected to be 19% of total revenue[26]

Company Overview - System1 operates an omnichannel marketing platform connecting customers with advertisers[19] - The company's platform, RAMP, identifies, markets to, and monetizes consumers across advertising verticals[21] - System1 processes over $754 million in advertising demand[22] - The company generates over 1 billion monthly sessions on owned and operated properties and across 260+ network partners[25] - System1 processes over 920 million queries per month[25] Financial Performance - System1's revenue is $334 million for the twelve months ending March 31, 2025[53] - The company's adjusted gross profit is $163 million[56] - System1's adjusted EBITDA is $50 million, representing a 30% margin on gross profit[58] Business Segments - O&O Marketing revenue less advertising expense is $84 million[28] - O&O Products revenue is $30 million[28] - Partner Network revenue is $56 million[28]

Qualys Enterprise TruRisk Platform - Qualys is transforming its focus to deliver desired business outcomes leveraging risk analytics with the Qualys Enterprise TruRisk Platform[10, 12] - The Qualys Enterprise TruRisk Platform offers comprehensive risk reduction by eliminating cyber risk, saving time, reducing MTTR, and consolidating the IT-security stack[20, 21] - The platform provides one view across the entire global hybrid-IT environment, allowing customers to consolidate their stack for better security outcomes, with no hardware to buy or manage[31] Market Opportunity and Customer Base - Qualys estimates its current total addressable market at $55 billion in CY2025E, expanding to $79 billion in CY2028E[35] - Qualys has a blue-chip global customer base of over 10,000 subscription customers[37] - 72% of the Forbes Global 50, 55% of the Forbes Global 500, and 33% of the Forbes Global 2000 are Qualys' subscription customers[37] Financial Performance - Qualys' 2024 revenues reached $608 million, with an adjusted EBITDA of $283 million, representing a 47% adjusted EBITDA margin[45] - The company's Q1 2025 revenues were $160 million, with an adjusted EBITDA of $75 million, maintaining a 47% adjusted EBITDA margin[45] - Qualys generated $232 million in free cash flow in 2024[50] - The company's adjusted EBITDA margin of 47% in 2024 is higher than the peer median of 25% for select security and SaaS companies[53]

Financial Performance - Corsair's Q1 2025 net revenue reached $369.8 million, a 9.6% increase year-over-year compared to $337.3 million in Q1 2024[40] - The company's gross profit for Q1 2025 was $102.4 million, representing an 18.1% increase from $86.6 million in Q1 2024[40] - Adjusted EBITDA for Q1 2025 was $22.6 million, a 25.6% increase compared to $18.0 million in Q1 2024[40] - Adjusted earnings per share (diluted) increased by 22.2% to $0.11 in Q1 2025, compared to $0.09 in Q1 2024[40] Segment Results - Gaming Components and Systems segment net revenue was $257.8 million in Q1 2025, an 11.9% increase year-over-year from $230.3 million in Q1 2024[41] - Gamer and Creator Peripherals segment net revenue reached $112.0 million in Q1 2025, a 4.7% increase compared to $107.0 million in Q1 2024[41] - Gross profit margin for the Gamer and Creator Peripherals segment was 41.5% in Q1 2025[41] Market Trends and Partnerships - US NPD data indicates a 20% year-over-year growth in the component and memory categories for March 2025[23] - Corsair has established partnerships with Call of Duty: Warzone, Porsche, and Bentley to enhance brand visibility and market reach[17, 18] FANATEC Integration - The Sim Racing category global TAM is estimated at over $1 billion and is expanding at a double-digit annual growth rate[24]

Q1 2025 EARNINGS PRESENTATION May 6, 2025 1 SAFE HARBOR This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as "guidance," "believe," "expect," "estimate," "project," "plan," "will," or words or phrases with s ...

Pipeline & Approvals - Ultragenyx expects a PDUFA date of August 18, 2025, for UX111 in Sanfilippo syndrome (MPS IIIA) and a potential commercial launch in the second half of 2025[67, 98] - The company anticipates BLA submission for DTX401 in Glycogen Storage Disease Type Ia (GSDIa) in mid-2025, with a potential launch in 2026[78, 80, 98] - Phase 3 enrollment for GTX-102 in Angelman Syndrome (AS) is expected to be completed in the second half of 2025, with a Phase 2/3 Aurora study initiation planned for 2025[46, 49, 61, 98] - Ultragenyx plans to complete Stage 1, Cohort 4 enrollment for UX701 in Wilson Disease (WD) in the second half of 2025[88, 90, 98] - Phase 3 data readout for UX143 in Osteogenesis Imperfecta (OI) is expected in 2025[21, 28, 32] Financial Performance & Projections - Ultragenyx projects total revenue between $640 million and $670 million in 2025, representing a 14-20% annual revenue growth[94, 95] - Crysvita revenue is projected to be between $460 million and $480 million in 2025, a 12-17% increase[95] - Dojolvi revenue is expected to be between $90 million and $100 million in 2025, a 2-13% increase[95] - The company aims to achieve full-year GAAP profitability in 2027, driven by revenue growth, expense management, and monetization of Priority Review Vouchers (PRVs)[2, 96, 97, 99] - Ultragenyx reported $563 million in cash, cash equivalents, and marketable debt securities as of March 31, 2025[97]

Q1 2025 Financial Performance - Porch Shareholder Interest revenue reached $84.5 million[16], with a gross profit of $69.1 million[16] and an impressive gross profit margin of 82%[16] - Adjusted EBITDA for Porch Shareholder Interest was $16.9 million[16], resulting in a 20% Adjusted EBITDA margin[16] - Cash flow from operations for Porch Shareholder Interest was $27.2 million[16] Segment Performance - Insurance Services generated $49.8 million in revenue with an 85% gross margin and a 52% Adjusted EBITDA margin[87] - Software & Data revenue was $22 million[34], with a 75% gross margin and a 21% Adjusted EBITDA margin[39] - Consumer Services revenue reached $14.7 million[34], boasting an 83% gross margin but a negative 5% Adjusted EBITDA margin due to investments for future growth[39] Guidance and Long-Term View - The company increased its 2025 Adjusted EBITDA guidance by $5 million to $65 million[59] (mid-point) - The company projects long-term (approximately 10 years) revenue of $2.3 billion and Adjusted EBITDA of $660 million[61] Reciprocal Performance - Reciprocal Written Premium (RWP) reached $97 million[16] - The Reciprocal maintains a healthy surplus of $198 million combined with non-admitted assets[18]

1Q 2025 Earnings Supplement May 6, 2025 Disclosures This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this presentation, including statements regarding the outcome of the operational and portfolio reviews, the costs, cash outlays, benefits, timing and financial impacts of the actions that may b ...